Donor or Recipient Hepatitis B Seropositivity Is Associated With Allograft Vasculopathy

This publication has 12 references indexed in Scilit:

• Donor hepatitis-C seropositivity is an independent risk factor for the development of accelerated coronary vasculopathy and predicts outcome after cardiac transplantation
  The Journal of Heart and Lung Transplantation, 2004
• The Role of Viruses in Cardiac Allograft Vasculopathy
  American Journal of Transplantation, 2004
• Does cytomegalovirus status influence acute and chronic rejection in heart transplantation during the ganciclovir prophylaxis era?
  The Journal of Heart and Lung Transplantation, 2003
• Long-term results of CMV hyperimmune globulin prophylaxis in 377 heart transplant recipients
  The Journal of Heart and Lung Transplantation, 2003
• Increased Prevalence of Carotid Atherosclerosis in Hepatitis B Virus Carriers
  Circulation, 2002
• Association of Viral Genome with Graft Loss in Children after Cardiac Transplantation
  New England Journal of Medicine, 2001
• Hepatitis virus infections in heart transplant recipients: Epidemiology, natural history, characteristics, and impact on survival
  Gastroenterology, 2000
• Virus-associated vasculitides
  Rheumatology, 1999
• Occult and Frequent Transmission of Atherosclerotic Coronary Disease With Cardiac Transplantation
  Circulation, 1995
• The Risk Of Transmission Of Hepatitis B From Hbsag(-), Hbcab(+), Hbigm(-) Organ Donors
  Transplantation, 1995